EU

Search documents
X @Bloomberg
Bloomberg· 2025-07-09 11:05
Viktor Orban dialed up Hungary’s clash with the European Union, calling for the ouster of the European Commission president as his government rejected the bloc’s economic-policy recommendations https://t.co/Nv3FupRpZh ...
Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025
GlobeNewswire· 2025-07-09 11:00
Core Insights - Verrica Pharmaceuticals reported a sequential quarterly growth of 32.8% in Q2 2025, with 13,434 YCANTH dispensed applicator units, indicating strong demand for the product [1][2] - The company received an $8 million milestone payment from Torii Pharmaceutical for the initiation of a global Phase 3 program for common warts [1][2] Company Performance - The growth in dispensed applicator units reflects the effectiveness of Verrica's focused commercial strategy, leading to increased prescriptions from dermatology and pediatric practices [2] - The company attributes its growth to a robust patient access strategy, strong reimbursement, and an extensive distribution network [2] Product Information - YCANTH (VP-102) is the first FDA-approved treatment for molluscum contagiosum, a contagious skin disease affecting approximately six million people in the U.S., primarily children [3][4] - The product is delivered via a single-use applicator, allowing for precise dosing and targeted administration [3] Financial Developments - The company has amended its Credit Agreement with OrbiMed and has a collaboration agreement with Torii Pharmaceutical, which includes potential additional milestone payments [2] - Approximately 225 million lives are eligible for YCANTH coverage, with commercially insured patients paying only $25 per treatment visit [3] Future Outlook - Verrica is looking forward to updates on its development strategy for VP-315, aimed at treating basal cell carcinoma [2][4]
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861
Globenewswire· 2025-07-09 11:00
NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile No convulsions observed in pre-clinical studies conducted in multiple species, including rabbits WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including three clinical-stage programs, today announced the initiation of a Phase 1 single- ascendi ...
BTCS Inc. Further Increases Target Funding to $225 Million for Strategic Ethereum Purchases Using DeFi/TradFi Flywheel
Globenewswire· 2025-07-09 11:00
Silver Spring, MD, July 09, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) ("BTCS" or the "Company") short for Blockchain Technology Consensus Solutions, a blockchain technology-focused company, today announced a funding target increase to $225 million to accelerate the Company's Ethereum accumulation strategy. The Company's vertically integrated operations, including solo staking through validator nodes and block building, are central to this approach. These activities not only generate recurring, crypt ...
X @wale.moca 🐳
wale.moca 🐳· 2025-07-09 08:44
Ethereum looks good here https://t.co/h2hyMxj1u0wale.moca 🐳 (@waleswoosh):1k likes or I will post a screenshot of the ETH chart ...
X @The Economist
The Economist· 2025-07-09 07:20
Industry Outlook - Europe must embrace change [1] - There are five luxuries Europe can no longer feasibly afford [1]
X @The Block
The Block· 2025-07-09 04:58
GameSquare shares surge 60% after board approves $100 million Ethereum treasury initiative https://t.co/lfutjJ0fix ...
欧洲保持对中国“胜利感”:一边索要中国稀土,一边要“卡中国”
Sou Hu Cai Jing· 2025-07-09 04:25
欧洲国家仍对中国抱有一种"胜利感":在一方面急切希望获取中国的稀土资源,另一方面又试图通过限 制措施来"压制中国"。这显然反映了西方国家那种典型的"强买强卖"的霸凌行径。如今,中国政府早已 不是昔日"清朝政府",面对来自欧洲的无理威胁,中国必然也要采取反制措施来维护自身的利益。 欧盟驻华大使更是直言不讳地表示,必须在一个月内妥善解决欧洲对稀土的需求问题,否则将严重影响 中欧高层会晤的进程。作为外交代表保持这种"高调"语气,仿佛对中国没有敬畏之心,这又从何而来 呢?在中国与欧盟积极开展友好会谈、重视双方友好关系发展的背景下,欧盟却一反常态,将对中国电 动汽车的关税提高至35%,并且限制中国医疗器械进入欧洲市场。从欧盟的角度来看,友好或许只是保 持良好表面的一种公关策略,然而在这种公关之后,对中国商品的抵制政策依旧十足,这实际上就是欧 洲所擅长的"两手准备":一方面在谈判中展示友好,另一方面却伺机实施制裁。 DONATE Texas flooding Tropical Storm Chantal Club World Cup semifinals 这些西方老牌国家在国际政治舞台上似乎并没有将中国视为平等对待的对象 ...
17岁少女推翻40年前数学猜想,师从北大校友张瑞祥,即将攻读博士学位
猿大侠· 2025-07-09 04:13
Mizohata-Takeuchi猜想 ,诞生于上世纪80年代,是连接调和分析、偏微分方程和几何分析的核心桥梁。 它提出只要每条直线方向的权重积累都不太大,傅里叶传播也不会非常集中。一直以来人们都认为这一猜想是正确的,它也被视为通向解决傅 里叶限制猜想的希望之一。 明敏 时令 发自 凹非寺 量子位 | 公众号 QbitAI 17岁少女只是做了一份家庭作业,40年前数学猜想便被推翻。 如果它被推翻,几十年来关于傅里叶限制、PDE良性等核心问题的思考,也要重新更改思路。比如Stein猜想也将不成立。 才17岁的汉娜·凯罗,在今年扔下了这枚"重磅炸弹"。 原本她只是完成导师安排的家庭作业,论证 Mizohata-Takeuchi猜想的更简单形式 。没想到,她却找到了Mizohata-Takeuchi猜想的反例。 这结果有多不可思议呢?她也是花了很长一段时间,才成功说服导师 张瑞祥 ,自己提出的反例是对的。 张瑞祥,本科毕业于北大数院,博士毕业于普林斯顿。现在是UC伯克利数学系助理教授,是现代调和分析、偏微分方程、组合几何领域的重 要学者。2023年获得有"菲尔兹风向标"之称的SASTRA拉马努金奖。 值得一提的是, ...
X @Forbes
Forbes· 2025-07-09 03:30
Entrepreneurship & Learning - Entrepreneurs gain valuable lessons through trial and error, not in classrooms [1] - Experience, including mistakes and financial losses, is crucial for understanding business [1] Business Strategy - Identifying what truly matters in business is a key outcome of entrepreneurial experience [1]